Pengfei Liu, PhD, FACMG is the Recipient of the 2022 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award from the ACMG Foundation for Genetic

BETHESDA, Md., March 23, 2022 /PRNewswire/ — Pengfei Liu, PhD, FACMG is the receiver of the ACMG Basis for Genetic and Genomic Medicine’s 2022 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award—the “Watson Award”—named for the American Higher education of Health care Genetics and Genomics 1st and longstanding govt director, Dr. Michael Watson, FACMG.

“It is my biggest privilege and honor to obtain the Michael S. Watson Genetic and Genomic Drugs Innovation Award from the ACMG Foundation. The previous ten years have been a time period of spectacular innovation in our discipline of human and clinical genetics,” claimed Dr. Liu. “I experience so fortuitous to have obtained my instruction and commenced my occupation for the duration of this time. I am thrilled to proceed this journey to translate reducing-edge technologies to medical implementation, and to increase the utilization of diagnostic significant knowledge.”

“Dr. Liu has been at the forefront of developing methods to harness significant genomic info sets to boost our skill to diagnose genetic problems. He is a true innovator in our industry, and, as these kinds of, highly deserving of recognition as the recipient of the Dr. Michael S. Watson Genetic and Genomic Drugs Innovation Award,” claimed Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Basis.

Pengfei Liu, PhD is an Assistant Professor at the Molecular and Human Genetics Department at Baylor Higher education of Medication (BCM), the Director of the ACGME-accredited Laboratory Genetics and Genomics (LGG) Fellowship Training System at BCM, and an Associate Medical Director at the Baylor Genetics diagnostic laboratory. He is a board-qualified laboratory geneticist who holds a PhD in molecular and human genetics from BCM.

Dr. Liu’s scientific contribution features utilizing clinical diagnostic huge data to produce information that developments genomic science, as properly as developing novel approaches to strengthen the implementation of genomic medication. He is a single of the recipients of the Genomic Innovator Award from the Nationwide Human Genome Study Institute. Dr. Liu has published in excess of 100 peer-reviewed articles in the industry of clinical genetics and genomics. He has been active in lots of NIH-funded crew science projects which includes the Undiagnosed Conditions Network (UDN), the GREGoR Consortium (Genomics Analysis to Elucidate the Genetics of Unusual health conditions, previously known as the Centre of Mendelian Genomics), the Prenatal Genetic Diagnosis by Genomic Sequencing (PrenatalSEQ), and the Unusual and Atypical Diabetic issues Network (RADIANT).

The Watson Award acknowledges those people who have demonstrated innovation in their function and made or carried out a new principle, process or strategy that has had important impact on genetic and genomic medication. The award was created to honor the part Dr. Watson played in the course of his nearly 20 many years at the helm of ACMG while the industry of genetic and genomic drugs emerged and progressed into the much-reaching apply it is right now, a period of time all through which Dr. Watson helped ACMG assume its situation at the forefront of coverage and guideline advancement.

“Dr. Pengfei Liu, a Fellow of the ACMG and Director of the LGG fellowship at BCM, is a perfect candidate for the Watson Award,” reported Max Muenke, MD, FACMG, CEO of the ACMG. “Dr. Liu’s do the job is innovative by combining laboratory diagnostics in individuals with unusual health conditions with innovative computational investigation.”

About the ACMG Foundation for Genetic and Genomic Medication

The ACMG Foundation for Genetic and Genomic Medication, a 501(c)(3) nonprofit group, is a community of supporters and contributors who recognize the worth of clinical genetics and genomics in healthcare. Set up in 1992, the ACMG Basis supports the American University of Clinical Genetics and Genomics (ACMG) mission to “translate genes into overall health.” Via its work, the ACMG Foundation fosters charitable providing, encourages schooling options to appeal to future medical geneticists and genetic counselors to the subject, shares info about health care genetics and genomics, and sponsors vital study. To study a lot more and assist the ACMG Foundation mission to build “Superior Well being via Genetics” visit www.acmgfoundation.org.              

Notice to editors: To organize interviews with authorities in healthcare genetics, call ACMG Senior Director of Communications and General public Relations, Kathy Moran, MBA at [email protected].

Supply American College or university of Health care Genetics and Genomics